Jabodon Pt CO Orchard Therapeutics PLC Transaction History

Jabodon Pt CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 12, 2020	SELL	$5.65 - $15.71 $1.23 Million - $3.41 Million	-217,164 Closed	0 $0
Q4 2019 Jan 31, 2020	BUY	$10.15 - $15.58 $745,141 - $1.14 Million	73,413 Added 51.07%	217,164 $2.99 Million
Q3 2019 Nov 13, 2019	BUY	$11.88 - $16.72 $398,015 - $560,170	33,503 Added 30.39%	143,751 $1.71 Million
Q2 2019 Aug 07, 2019	BUY	$13.2 - $20.63 $1.05 Million - $1.64 Million	79,496 Added 258.51%	110,248 $1.54 Million
Q1 2019 May 10, 2019	BUY	$12.01 - $19.49 $369,331 - $599,356	30,752 New	30,752 $550,000

545K

Ticker ORTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,458,000
Description
Orchard Therapeutics plc, a biopharmaceutical company, develops gene therapies for serious and life-threatening rare diseases in the United Kingdom, European Union, and the United States. The company's gene therapy approach seeks to transform a patient's hematopoietic stem cells into a gene-modified cellular drug product to treat the patient's d...

Get notified when there are updates to the investment portfolio of Jabodon Pt CO, based on Form 13F filings with the SEC.

Stay updated on Jabodon Pt CO with notifications on news.